Memorial Sloan Kettering Commack (Consent and Follow-up Only) is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Commack (Consent and Follow-up Only) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL).
Sponsors: Memorial Sloan Kettering Cancer Center.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Commack (Consent and Follow-up Only) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Commack (Consent and Follow-up Only) has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL).
Memorial Sloan Kettering Commack (Consent and Follow-up Only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.